Discover
SION
Sionna Therapeutics, Inc.
4.80
2 x 35.98
2 x 64.74
bid
ask
-
0.02
0.41%
12:54 PM
timesize
| Ytd | -88.33% | |
| 1y | -83.16% |
4.65
day range
4.82
4.01
52 week range
54.97
| Open | 4.78 | Prev Close | 4.82 | Low | 4.65 | High | 4.82 | Mkt Cap | 217.02M |
| Vol | 174.14K | Avg Vol | 2.19M | EPS | -2.16 | P/E | N/A | Forward P/E | -18.18 |
| Beta | 1.00 | Short Ratio | 10.62 | Inst. Own | 100.23% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 12.82 | 200-d Avg | 33.22 | 1yr Est | 53.20 |
| Income Statement | |||
| Operating Expenses | 32.47M | ||
| Research and Development Expense | 21.86M | ||
| Selling, General and Administrative Expense | 10.61M | ||
| Operating Income | -32.47M | ||
| Net Income | -29.89M | ||
| Net Income Common Stock | -29.89M | ||
| Net Income Common Stock (USD) | -29.89M | ||
| Consolidated Income | -29.89M | ||
| Earnings per Basic Share | -0.66 | ||
| Earnings per Basic Share (USD) | -0.66 | ||
| Earnings per Diluted Share | -0.66 | ||
| Earning Before Interest & Taxes (EBIT) | -29.89M | ||
| Earning Before Interest & Taxes (USD) | -29.89M | ||
| Weighted Average Shares | 45.15M | ||
| Weighted Average Shares Diluted | 45.15M | ||
| Balance Sheet | |||
| Cash and Equivalents | 64.29M | ||
| Cash and Equivalents (USD) | 64.29M | ||
| Investments | 204.93M | ||
| Investments Current | 147.71M | ||
| Investments Non-Current | 57.22M | ||
| Current Assets | 216.13M | ||
| Property, Plant & Equipment Net | 8.34M | ||
| Total Assets | 283.25M | ||
| Debt Current | 1.38M | ||
| Total Debt | 8.07M | ||
| Current Liabilities | 10.78M | ||
| Debt Non-Current | 6.69M | ||
| Total Liabilities | 17.47M | ||
| Accumulated Retained Earnings (Deficit) | -313.02M | ||
| Accumulated Other Comprehensive Income | -448.00K | ||
| Shareholders Equity | 265.77M | ||
| Shareholders Equity (USD) | 265.77M | ||
| Assets Non-Current | 67.12M | ||
| Total Debt (USD) | 8.07M | ||
| Liabilities Non-Current | 6.69M | ||
| Trade and Non-Trade Payables | 523.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 647.00K | ||
| Net Cash Flow from Financing | 749.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.00K | ||
| Issuance (Purchase) of Equity Shares | 979.00K | ||
| Net Cash Flow from Investing | 21.47M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 21.47M | ||
| Net Cash Flow from Operations | -22.22M | ||
| Share Based Compensation | 6.84M | ||